Published in J Virol on July 01, 2003
Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome. Proc Natl Acad Sci U S A (2006) 1.22
RNA-RNA and RNA-protein interactions in coronavirus replication and transcription. RNA Biol (2011) 1.21
Genetic evidence of a long-range RNA-RNA interaction between the genomic 5' untranslated region and the nonstructural protein 1 coding region in murine and bovine coronaviruses. J Virol (2012) 0.87
The structure and functions of coronavirus genomic 3' and 5' ends. Virus Res (2015) 0.87
Functional analysis of the murine coronavirus genomic RNA packaging signal. J Virol (2013) 0.86
Structure and functional relevance of a transcription-regulating sequence involved in coronavirus discontinuous RNA synthesis. J Virol (2011) 0.84
High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling. PLoS Pathog (2016) 0.78
Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein. J Virol (2014) 0.78
A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging. Virology (2016) 0.75
Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J Virol (2002) 4.29
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol (1980) 3.82
Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc Natl Acad Sci U S A (1989) 3.65
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
Studies on transmissible gastroenteritis of swine. II. Selected characteristics of a cytopathogenic virus common to five isolates from transmissible gastroenteritis. Can J Comp Med Vet Sci (1966) 3.42
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J (1994) 2.86
A new model for coronavirus transcription. Adv Exp Med Biol (1998) 2.75
Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (2000) 2.73
Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles. J Virol (1980) 2.42
Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol (1999) 2.38
Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol (2001) 2.36
Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J Virol (2000) 2.35
Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J Virol (1991) 2.27
Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol (2001) 2.19
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Critical epitopes in transmissible gastroenteritis virus neutralization. J Virol (1986) 2.05
Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol (1979) 2.04
Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J Virol (1998) 2.03
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology (1990) 2.00
Portable encapsidation signal of the L-A double-stranded RNA virus of S. cerevisiae. Cell (1990) 2.00
RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment. J Virol (2000) 1.96
Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture. J Virol (1990) 1.92
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J Virol (2001) 1.84
The proximate 5' and 3' ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage phi 29 DNA. Virology (1994) 1.76
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol (2001) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
Complete genome sequence of transmissible gastroenteritis coronavirus PUR46-MAD clone and evolution of the purdue virus cluster. Virus Genes (2001) 1.70
The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J Virol (1996) 1.69
Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol (2002) 1.69
Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J Virol (2002) 1.57
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Evidence for segment-nonspecific packaging of the influenza a virus genome. J Virol (2002) 1.51
Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology (1991) 1.51
Protein interactions during coronavirus assembly. J Virol (1997) 1.49
cis-Acting signals in encapsidation of Hantaan virus S-segment viral genomic RNA by its N protein. J Virol (2001) 1.48
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Host protein interactions with the 3' end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J Virol (2000) 1.40
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus. J Virol (2002) 1.38
Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet Res (1993) 1.38
cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA. J Virol (1996) 1.35
Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J Virol (1992) 1.32
Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes. J Virol (1999) 1.31
cis Requirement for N-specific protein sequence in bovine coronavirus defective interfering RNA replication. J Virol (1996) 1.30
Identification of a packaged cellular mRNA in virions of rous sarcoma virus. J Virol (1981) 1.23
Identification of a region of the rabies virus N protein involved in direct binding to the viral RNA. J Gen Virol (1998) 1.22
A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions. J Virol (1997) 1.22
Subgenomic mRNA of Aura alphavirus is packaged into virions. J Virol (1994) 1.21
In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J Gen Virol (2000) 1.20
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol (2003) 1.19
Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1. J Virol (1988) 1.13
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
Replication of synthetic defective interfering RNAs derived from coronavirus mouse hepatitis virus-A59. Virology (1996) 1.12
cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J Virol (2001) 1.12
The ends on herpesvirus DNA replicative concatemers contain pac2 cis cleavage/packaging elements and their formation is controlled by terminal cis sequences. J Virol (2000) 1.11
Stabilization of a full-length infectious cDNA clone of transmissible gastroenteritis coronavirus by insertion of an intron. J Virol (2002) 1.10
Identification of a bovine coronavirus packaging signal. J Virol (2000) 1.09
Presence of subgenomic mRNAs in virions of coronavirus IBV. Virology (1993) 1.08
Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol (2001) 1.04
Importance of the positive-strand RNA secondary structure of a murine coronavirus defective interfering RNA internal replication signal in positive-strand RNA synthesis. J Virol (1998) 1.02
Aura alphavirus subgenomic RNA is packaged into virions of two sizes. J Virol (1995) 0.98
Host cell proteins binding to the encapsidation signal epsilon in hepatitis B virus RNA. Arch Virol (2002) 0.95
Coronavirus transcription early in infection. J Virol (1998) 0.95
Positional effect of deletions on viability, especially on encapsidation, of Brome mosaic virus D-RNA in barley protoplasts. Virology (2002) 0.93
A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal. J Virol (1997) 0.92
Structure elucidation of the hepatitis B virus encapsidation signal by NMR on selectively labeled RNAs. J Biomol Struct Dyn (2002) 0.91
RNA secondary structures of the bacteriophage phi6 packaging regions. RNA (2000) 0.90
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
Recognition of RNA encapsidation signal by the yeast L-A double-stranded RNA virus. J Biol Chem (2000) 0.81
Coronavirus nucleocapsid protein. RNA interactions. Adv Exp Med Biol (1998) 0.79
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Nidovirales: evolving the largest RNA virus genome. Virus Res (2006) 3.41
A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol (2003) 2.35
Sequence motifs involved in the regulation of discontinuous coronavirus subgenomic RNA synthesis. J Virol (2004) 2.30
Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A (2014) 2.17
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology (2010) 1.79
The nucleoprotein is required for efficient coronavirus genome replication. J Virol (2004) 1.68
Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J Virol (2002) 1.57
Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis. J Virol (2006) 1.57
A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol (2006) 1.51
Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. J Virol (2005) 1.49
Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology (2003) 1.45
Transcription regulatory sequences and mRNA expression levels in the coronavirus transmissible gastroenteritis virus. J Virol (2002) 1.38
A pilot clinical study of hair grafting in chronic leg ulcers. Wound Repair Regen (2012) 1.35
Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio (2013) 1.34
Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog (2012) 1.34
Compartmentalization of VP16 in cells infected with recombinant herpes simplex virus expressing VP16-green fluorescent protein fusion proteins. J Virol (2004) 1.33
Virology. The SARS coronavirus: a postgenomic era. Science (2003) 1.31
Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication. PLoS One (2008) 1.29
Clinical translation of stem cell therapies: a bridgeable gap. Cell Stem Cell (2010) 1.29
Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog (2011) 1.29
Coronavirus nucleocapsid protein is an RNA chaperone. Virology (2006) 1.28
Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J Virol (2003) 1.25
RNA-RNA and RNA-protein interactions in coronavirus replication and transcription. RNA Biol (2011) 1.21
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology (2008) 1.17
Reflections on how wound healing-promoting effects of the hair follicle can be translated into clinical practice. Exp Dermatol (2014) 1.15
Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway. Virology (2007) 1.15
Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog (2011) 1.11
Stabilization of a full-length infectious cDNA clone of transmissible gastroenteritis coronavirus by insertion of an intron. J Virol (2002) 1.10
Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol (2013) 1.10
Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother (2012) 1.08
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J Gen Virol (2005) 1.07
Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. J Virol (2006) 1.06
Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol (2009) 1.06
Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int J Infect Dis (2008) 1.06
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. J Virol (2008) 1.05
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS One (2008) 1.04
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein. Virology (2011) 1.04
Recombinant canine coronaviruses related to transmissible gastroenteritis virus of Swine are circulating in dogs. J Virol (2008) 1.01
Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism. J Virol (2012) 0.99
Age-dependent depletion of human skin-derived progenitor cells. Stem Cells (2009) 0.99
Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology (2012) 0.99
Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins. J Virol (2002) 0.97
Identification of a coronavirus transcription enhancer. J Virol (2008) 0.95
Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein. J Gen Virol (2011) 0.94
Development of a transgenic mouse model susceptible to human coronavirus 229E. Proc Natl Acad Sci U S A (2005) 0.94
Host cell proteins interacting with the 3' end of TGEV coronavirus genome influence virus replication. Virology (2009) 0.94
A novel sorting signal for intracellular localization is present in the S protein of a porcine coronavirus but absent from severe acute respiratory syndrome-associated coronavirus. J Biol Chem (2004) 0.93
Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication. J Virol (2008) 0.93
Human epithelial hair follicle stem cells and their progeny: current state of knowledge, the widening gap in translational research and future challenges. Bioessays (2014) 0.93
The use of transient expression systems for the rapid production of virus-like particles in plants. Curr Pharm Des (2013) 0.92
Role of RNA chaperones in virus replication. Virus Res (2008) 0.92
Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol (2012) 0.91
Alphacoronavirus protein 7 modulates host innate immune response. J Virol (2013) 0.89
In vitro and in vivo expression of foreign genes by transmissible gastroenteritis coronavirus-derived minigenomes. J Gen Virol (2002) 0.87
Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge. Biochim Biophys Acta (2013) 0.86
Production of human tissue-engineered skin trilayer on a plasma-based hypodermis. J Tissue Eng Regen Med (2012) 0.86
Modeling neural differentiation on micropatterned substrates coated with neural matrix components. Front Cell Neurosci (2012) 0.86
A novel porcine reproductive and respiratory syndrome virus vector system that stably expresses enhanced green fluorescent protein as a separate transcription unit. Vet Res (2013) 0.85
Vectored vaccines to protect against PRRSV. Virus Res (2010) 0.85
Immunopurification applied to the study of virus protein composition and encapsidation. J Virol Methods (2004) 0.84
Structure and functional relevance of a transcription-regulating sequence involved in coronavirus discontinuous RNA synthesis. J Virol (2011) 0.84
Gene N proximal and distal RNA motifs regulate coronavirus nucleocapsid mRNA transcription. J Virol (2011) 0.84
Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Res (2011) 0.84
Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J Gen Virol (2012) 0.83
The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated. Virology (2010) 0.83
Studying human pathogens in animal models: fine tuning the humanized mouse. Transgenic Res (2005) 0.82
Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes. Methods Mol Biol (2008) 0.82
Morphometric analysis of the human scalp hair follicle: practical implications for the hair transplant surgeon and hair regeneration studies. Dermatol Surg (2010) 0.82
Nature of the virus associated with endemic Balkan nephropathy. Emerg Infect Dis (2002) 0.81
Functional characterization of highly adherent CD34+ keratinocytes isolated from human skin. Exp Dermatol (2010) 0.81
The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus. Virol J (2011) 0.81
A point mutation within the replicase gene differentially affects coronavirus genome versus minigenome replication. J Virol (2005) 0.81
Biochemical aspects of coronavirus replication. Adv Exp Med Biol (2006) 0.80
A neural extracellular matrix-based method for in vitro hippocampal neuron culture and dopaminergic differentiation of neural stem cells. BMC Neurosci (2013) 0.79
The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines. J Virol Methods (2013) 0.79
Long-distance RNA-RNA interactions in the coronavirus genome form high-order structures promoting discontinuous RNA synthesis during transcription. J Virol (2012) 0.79
Lactase persistence, NOD2 status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel Disease. Gut Pathog (2012) 0.79
Use of virus vectors for the expression in plants of active full-length and single chain anti-coronavirus antibodies. Biotechnol J (2006) 0.79
Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo. J Gen Virol (2007) 0.78
Rapid differentiation of vaccine strain and Chinese field strains of transmissible gastroenteritis virus by restriction fragment length polymorphism of the N gene. Virus Genes (2010) 0.78
Immunogenic characterization and epitope mapping of transmissible gastroenteritis virus RNA dependent RNA polymerase. J Virol Methods (2011) 0.78
Identification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA. Adv Exp Med Biol (2006) 0.78
An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts. Plant Biotechnol J (2006) 0.78
Molecular characterization of a Chinese vaccine strain of transmissible gastroenteritis virus: mutations that may contribute to attenuation. Virus Genes (2010) 0.77
Purification and characterization of the Caenorhabditis elegans HCF protein and domains of human HCF. Biochemistry (2005) 0.77
RNA virus replication, transcription and recombination. RNA Biol (2011) 0.77
Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus. J Gen Virol (2009) 0.77
Transmissible gastroenteritis coronavirus RNA-dependent RNA polymerase and nonstructural proteins 2, 3, and 8 are incorporated into viral particles. J Virol (2011) 0.77
Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens. Clin Diagn Lab Immunol (2004) 0.77
Murine muscle engineered from dermal precursors: an in vitro model for skeletal muscle generation, degeneration, and fatty infiltration. Tissue Eng Part C Methods (2013) 0.76